Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693745 · ClinicalTrials.gov registry record
Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 231
- Enrollment target
NCT00693745 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 231 participants.
The verdict
NCT00693745 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 231 participants
- Enrollment target
Study Summary
This is a multi-center prospective pilot clinical study to assess the utility of the Triage NGAL Test - alone and in conjunction with the Triage BNP test - as an aid in the early risk assessment for heart-failure-related adverse clinical outcomes (deaths, readmissions, and additional emergent outpatient visits) through Day 30 and Day 90 in patients presenting with acutely decompensated heart failure (HF). Its utility as an aid in the early risk assessment for renal dysfunction in patients with acutely decompensated heart failure undergoing treatment with IV diuretics will also be assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00693745
The ClinicalTrials.gov registry entry for NCT00693745 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00693745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00693745 about?
NCT00693745 is a clinical study titled "Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF". This is a multi-center prospective pilot clinical study to assess the utility of the Triage NGAL Test - alone and in conjunction with the Triage BNP test - as an aid in the early risk assessment for heart-failure-related adverse clinical outcomes (deaths, readmissions, and additional emergent outpat...
What is the current status of trial NCT00693745?
This trial is currently completed. The enrollment target is 231 participants. The study started on 2008-09. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT00693745?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.